vs

Side-by-side financial comparison of Smith Douglas Homes Corp. (SDHC) and Sotera Health Co (SHC). Click either name above to swap in a different company.

Sotera Health Co is the larger business by last-quarter revenue ($303.4M vs $260.4M, roughly 1.2× Smith Douglas Homes Corp.). Sotera Health Co runs the higher net margin — 11.5% vs 1.4%, a 10.1% gap on every dollar of revenue. On growth, Sotera Health Co posted the faster year-over-year revenue change (4.6% vs -9.4%). Sotera Health Co produced more free cash flow last quarter ($52.4M vs $8.7M). Over the past eight quarters, Smith Douglas Homes Corp.'s revenue compounded faster (17.3% CAGR vs 10.6%).

Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.

Sotera Health Co is a global provider of end-to-end medical safety solutions. It offers sterilization services, analytical laboratory testing, and regulatory advisory support for medical device manufacturers, pharmaceutical firms, and food and consumer product companies, helping clients meet industry standards and ensure product safety for end users worldwide.

SDHC vs SHC — Head-to-Head

Bigger by revenue
SHC
SHC
1.2× larger
SHC
$303.4M
$260.4M
SDHC
Growing faster (revenue YoY)
SHC
SHC
+14.0% gap
SHC
4.6%
-9.4%
SDHC
Higher net margin
SHC
SHC
10.1% more per $
SHC
11.5%
1.4%
SDHC
More free cash flow
SHC
SHC
$43.7M more FCF
SHC
$52.4M
$8.7M
SDHC
Faster 2-yr revenue CAGR
SDHC
SDHC
Annualised
SDHC
17.3%
10.6%
SHC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SDHC
SDHC
SHC
SHC
Revenue
$260.4M
$303.4M
Net Profit
$3.5M
$34.8M
Gross Margin
19.9%
54.7%
Operating Margin
6.5%
23.2%
Net Margin
1.4%
11.5%
Revenue YoY
-9.4%
4.6%
Net Profit YoY
-14.3%
182.8%
EPS (diluted)
$0.39
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SDHC
SDHC
SHC
SHC
Q4 25
$260.4M
$303.4M
Q3 25
$262.0M
$311.3M
Q2 25
$223.9M
$294.3M
Q1 25
$224.7M
$254.5M
Q4 24
$287.5M
$290.2M
Q3 24
$277.8M
$285.5M
Q2 24
$220.9M
$276.6M
Q1 24
$189.2M
$248.2M
Net Profit
SDHC
SDHC
SHC
SHC
Q4 25
$3.5M
$34.8M
Q3 25
$2.1M
$48.4M
Q2 25
$2.4M
$8.0M
Q1 25
$2.7M
$-13.3M
Q4 24
$4.1M
$12.3M
Q3 24
$5.3M
$17.0M
Q2 24
$3.6M
$8.8M
Q1 24
$3.0M
$6.3M
Gross Margin
SDHC
SDHC
SHC
SHC
Q4 25
19.9%
54.7%
Q3 25
21.0%
57.0%
Q2 25
23.2%
56.6%
Q1 25
23.8%
53.2%
Q4 24
25.5%
56.6%
Q3 24
26.5%
55.4%
Q2 24
26.7%
55.2%
Q1 24
26.1%
51.2%
Operating Margin
SDHC
SDHC
SHC
SHC
Q4 25
6.5%
23.2%
Q3 25
6.6%
23.4%
Q2 25
7.7%
6.4%
Q1 25
8.7%
-5.8%
Q4 24
10.4%
30.0%
Q3 24
14.2%
28.2%
Q2 24
11.7%
27.8%
Q1 24
11.3%
21.4%
Net Margin
SDHC
SDHC
SHC
SHC
Q4 25
1.4%
11.5%
Q3 25
0.8%
15.5%
Q2 25
1.1%
2.7%
Q1 25
1.2%
-5.2%
Q4 24
1.4%
4.2%
Q3 24
1.9%
6.0%
Q2 24
1.7%
3.2%
Q1 24
1.6%
2.5%
EPS (diluted)
SDHC
SDHC
SHC
SHC
Q4 25
$0.39
$0.12
Q3 25
$0.24
$0.17
Q2 25
$0.26
$0.03
Q1 25
$0.30
$-0.05
Q4 24
$0.50
$0.05
Q3 24
$0.58
$0.06
Q2 24
$0.40
$0.03
Q1 24
$0.33
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SDHC
SDHC
SHC
SHC
Cash + ST InvestmentsLiquidity on hand
$12.7M
$344.6M
Total DebtLower is stronger
$2.1B
Stockholders' EquityBook value
$86.7M
$606.0M
Total Assets
$557.6M
$3.3B
Debt / EquityLower = less leverage
3.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SDHC
SDHC
SHC
SHC
Q4 25
$12.7M
$344.6M
Q3 25
$14.8M
$299.2M
Q2 25
$16.8M
$332.4M
Q1 25
$12.7M
$304.4M
Q4 24
$22.4M
$277.2M
Q3 24
$23.7M
$306.7M
Q2 24
$17.3M
$246.1M
Q1 24
$32.8M
$261.1M
Total Debt
SDHC
SDHC
SHC
SHC
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$2.2B
Q2 24
$2.2B
Q1 24
$2.2B
Stockholders' Equity
SDHC
SDHC
SHC
SHC
Q4 25
$86.7M
$606.0M
Q3 25
$82.2M
$550.5M
Q2 25
$80.0M
$511.3M
Q1 25
$76.9M
$414.1M
Q4 24
$73.6M
$404.9M
Q3 24
$68.4M
$470.2M
Q2 24
$62.1M
$422.8M
Q1 24
$59.7M
$429.4M
Total Assets
SDHC
SDHC
SHC
SHC
Q4 25
$557.6M
$3.3B
Q3 25
$571.6M
$3.2B
Q2 25
$570.2M
$3.2B
Q1 25
$513.9M
$3.1B
Q4 24
$475.9M
$3.1B
Q3 24
$460.1M
$3.1B
Q2 24
$429.3M
$3.1B
Q1 24
$401.3M
$3.1B
Debt / Equity
SDHC
SDHC
SHC
SHC
Q4 25
3.53×
Q3 25
3.89×
Q2 25
4.34×
Q1 25
5.36×
Q4 24
5.49×
Q3 24
4.73×
Q2 24
5.26×
Q1 24
5.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SDHC
SDHC
SHC
SHC
Operating Cash FlowLast quarter
$9.8M
$103.1M
Free Cash FlowOCF − Capex
$8.7M
$52.4M
FCF MarginFCF / Revenue
3.4%
17.3%
Capex IntensityCapex / Revenue
0.4%
16.7%
Cash ConversionOCF / Net Profit
2.77×
2.96×
TTM Free Cash FlowTrailing 4 quarters
$-36.9M
$149.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SDHC
SDHC
SHC
SHC
Q4 25
$9.8M
$103.1M
Q3 25
$22.8M
$71.2M
Q2 25
$-28.9M
$57.4M
Q1 25
$-34.9M
$55.5M
Q4 24
$5.5M
$55.7M
Q3 24
$22.9M
$97.5M
Q2 24
$39.0K
$61.3M
Q1 24
$-9.3M
$9.7M
Free Cash Flow
SDHC
SDHC
SHC
SHC
Q4 25
$8.7M
$52.4M
Q3 25
$21.4M
$35.0M
Q2 25
$-31.1M
$26.2M
Q1 25
$-35.9M
$35.6M
Q4 24
$4.8M
$-10.2M
Q3 24
$22.3M
$61.1M
Q2 24
$-2.1M
$19.4M
Q1 24
$-9.7M
$-25.2M
FCF Margin
SDHC
SDHC
SHC
SHC
Q4 25
3.4%
17.3%
Q3 25
8.2%
11.2%
Q2 25
-13.9%
8.9%
Q1 25
-16.0%
14.0%
Q4 24
1.7%
-3.5%
Q3 24
8.0%
21.4%
Q2 24
-1.0%
7.0%
Q1 24
-5.1%
-10.2%
Capex Intensity
SDHC
SDHC
SHC
SHC
Q4 25
0.4%
16.7%
Q3 25
0.5%
11.6%
Q2 25
0.9%
10.6%
Q1 25
0.5%
7.8%
Q4 24
0.2%
22.7%
Q3 24
0.2%
12.7%
Q2 24
1.0%
15.2%
Q1 24
0.2%
14.1%
Cash Conversion
SDHC
SDHC
SHC
SHC
Q4 25
2.77×
2.96×
Q3 25
10.70×
1.47×
Q2 25
-12.24×
7.21×
Q1 25
-13.01×
Q4 24
1.33×
4.52×
Q3 24
4.28×
5.73×
Q2 24
0.01×
7.00×
Q1 24
-3.12×
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SDHC
SDHC

Southeast$164.7M63%
Central$95.8M37%

SHC
SHC

Transferred At Point In Time$198.4M65%
Nelson Labs$55.2M18%
Nordion$49.8M16%

Related Comparisons